FindTrial
Sign In

A study on bone mineral density of men and women with fractures of hip, spine and distal radius and management of associated osteoporosis

A study on bone mineral density of men and women with fractures of hip, spine and distal radius

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030158
Enrollment
132
Registered
2020-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M800- Age-related osteoporosis with current pathological fracture

Interventions

Intervention1: Teriparatide: 20 mcg subcutaneously once a day for 2 years Intervention2: Zolindronic Acid 5mg: Intravenous infusion Once a year, 2 doses Intervention3: Alendronate 35mg: Once a week or

Sponsors

Manipal Academy of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Both men and women fractures of hip, spine, and distal radius 2. Willing to participate in study

Exclusion criteria

Exclusion criteria: 1. Fractures followed by road traffic accidents (RTA) 2. Pathological fractures other than osteoporosis

Design outcomes

Primary

MeasureTime frame
Bone Mineral Density by DEXA Efficacy of treatment Timepoint: 2 years—

Secondary

MeasureTime frame
Evaluation by three forms of treatment (pre- and post-treatment)Timepoint: 2 years after recruitment—

Countries

India

Contacts

Public ContactShyamasunder Bhat N

Manipal Academy of Higher Education

shyambhat.n@manipal.edu9480486075

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026